Adjusted Fibrinogen Replacement Strategy

Clinical trial NCT03444324 · COMPLETED

Trial details

NCT number: NCT03444324
Sponsor: Biotest
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bleeding Disorder Hypofibrinogenemia; Acquired

Start date: 2018-04-03
Primary completion: 2023-09-25
Enrollment: 222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.